Assistive Robots Market Size, Share, and Growth Forecast 2026 - 2033

The global assistive robots market size is expected to be valued at US$18.3 billion in 2026 and projected to reach US$85.3 billion by 2033, growing at a CAGR of 24.6% during the forecast period from 2026 to 2033, driven by propelled by the intersection of aging populations and technological advancements in robotics and AI. This growth is evidenced by surging adoption in elderly care and surgical precision, where robots enhance mobility and reduce human error.

• Dominant Region: North America is projected to dominate, capturing 38% of revenue in 2026, driven by strong clinical adoption, reimbursement support, and a mature innovation ecosystem across hospitals, rehabilitation centers, and homecare programs.
• Fastest-growing Region: Asia Pacific, driven by manufacturing scale, policy support, and rapid clinical adoption, with Cyberdyne Inc. deploying exoskeletons across Japanese hospitals and rehab centers.
• Dominant Product Type: Fixed-base robots are expected to lead the product type, with over 55% share in 2026, owing to widespread adoption in clinical and therapeutic environments where stable platforms provide consistent support for users.
• Leading Application: Elderly assistance is expected to dominate, with over 42% share for mobility support.

Growth Analysis - Aging Population and Rising Disability Rates

Global demographic shifts are expanding the population that requires daily assistance, rehabilitation support, and mobility solutions. The World Health Organization (WHO) reports that over 1.3 billion people worldwide live with significant disability, representing about 16% of the global population, creating sustained demand for assistive technologies in home and clinical settings. Government census and public health data also show rapid growth in older age groups; the United Nations Department of Economic and Social Affairs (UN DESA) projects that the global population aged 65 years and above will rise from 761 million in 2021 to 1.6 billion by 2050, reflecting a sharp increase in age-related mobility limitations and care needs. These trends raise pressure on healthcare systems to deliver continuous support with limited human resources, strengthening the case for assistive robots in mobility aid, daily living assistance, and patient monitoring.

Public health agencies link aging and disability with a higher prevalence of functional limitations that restrict independent living. The U.S. Centers for Disease Control and Prevention (CDC) reports that one in four adults in the U.S. lives with a disability, with mobility and self-care among the most common limitations, driving demand for robotic assistance in transfers, rehabilitation, and home support. Government health surveys also show that older adults experience higher rates of falls and post-acute care needs, which increases reliance on technology-enabled support solutions in homecare and rehabilitation programs. Assistive robots address workforce shortages in caregiving and enable continuous support for daily activities, rehabilitation exercises, and monitoring, reinforcing their role as scalable tools for aging societies.

Advancements in AI and Sensor Technologies

Rapid progress in federal support for artificial intelligence (AI) research has underpinned enhanced autonomy and perception capabilities in assistive robots, enabling safer and more intuitive human-robot interaction. The U.S. National Science Foundation (NSF) annually invests over US$700 million in foundational AI research across computing, autonomy, and machine learning, which directly contributes to robots’ ability to plan, sense, and adapt to dynamic environments such as healthcare settings and homes. These innovations are critical for tasks like navigation in cluttered spaces, real-time decision-making, and personalized assistance for individuals with mobility limitations. The National Robotics Initiative and related robotics programs supported by NSF and partner agencies promote collaborative robots designed to work alongside humans, expanding assistive applications while boosting reliability and contextual awareness. This sustained public funding strengthens the R&D ecosystem and accelerates the translation of AI advances into commercial assistive robots.

Government efforts to develop rigorous sensor and perception standards reduce risks associated with deploying AI-enabled robots in close proximity to people. For example, NIST’s robotics sensing and perception programs focus on measurement science that advances agility, autonomy, and safety in robotic systems by improving perception benchmarks and performance evaluation for vision and 3D imaging systems. These efforts support the adoption of high-precision sensors and AI algorithms that enhance object recognition, localization, motion estimation, and human tracking, enabling robots to respond reliably in everyday assistance scenarios.

Barrier Analysis: Complex Regulatory and Certification Requirements

Regulatory approval pathways add time, cost, and complexity to the commercialization of assistive robots used in healthcare and homecare. In the U.S., products intended for clinical use must comply with U.S. Food and Drug Administration (FDA) requirements, including premarket submissions, safety testing, clinical evidence, and post-market surveillance. These processes lengthen development timelines and raise compliance costs, which challenge startups and smaller manufacturers. In Europe, devices used for medical purposes must obtain CE marking under the EU Medical Device Regulation (MDR), which strengthened clinical evaluation and technical documentation obligations.

Cross-border commercialization faces further hurdles from data protection and safety standards. Robots that capture images, audio, or biometric data must align with GDPR privacy-by-design principles, requiring secure data handling, consent management, and cybersecurity controls. Safety conformity with ISO standards for personal care robots requires rigorous risk management and usability validation. Together, these layered requirements extend approval timelines, elevate certification costs, and complicate multi-region launches, slowing deployment across care settings.

Limited Interoperability with Legacy Healthcare Systems

Limited interoperability with legacy healthcare systems restricts the smooth deployment of assistive robots across hospitals, rehabilitation centers, and homecare networks. Many facilities rely on long-standing electronic health record platforms and device ecosystems built on proprietary interfaces, which complicates real-time data exchange with robots that generate mobility metrics, vital sign inputs, or activity logs. In the U.S., national interoperability rules under ONC promote standardized data exchange using FHIR and HL7, yet uneven adoption across providers creates gaps in connectivity.

Assistive robots may operate as standalone tools rather than integrated components of care workflows, reducing clinical efficiency and continuity of care. Cybersecurity and privacy requirements under HIPAA further limit direct system-to-system integration without certified interfaces and secure identity management. These constraints increase integration costs, delay deployments, and place additional burdens on IT teams, slowing procurement decisions and reducing the scalability of assistive robotics across multi-site healthcare networks.

Opportunity Analysis: Expansion in Surgery Assistance Segment

Robotic surgery has seen rapid adoption across a range of procedures, creating a significant opportunity for assistive robots in surgical settings. In the U.S., the use of robotic systems for general surgery procedures rose markedly over recent years, increasing from about 1.8% of procedures in 2012 to around 15.1% by 2018, demonstrating a broad shift toward robot-assisted operations as hospitals expand their robotics programs. A growing base of facilities performing robotic surgery reflects increased confidence in precision, ergonomic control, and minimally invasive approaches, which support better outcomes and faster recovery for patients.

Government and healthcare systems are reinforcing this trend through policy and investment. For example, numerous NHS plans in the U.K. aim to expand robot-assisted surgeries from roughly one in sixty to higher proportions over the coming decade, highlighting strategic emphasis on robotics to improve care delivery and reduce waiting times. This trajectory underscores the expanding role of assistive robotic technology in operating rooms, presenting a major growth opportunity for developers of surgical assistance platforms and related support solutions.

Rehabilitation Centers Emerge as a High-Growth End-user Segment

Expansion of rehabilitation services and supportive care environments is strengthening demand for assistive robots that support physical therapy, mobility training, and functional recovery. In the U.S., federal health statistics show that nearly 10 million people receive outpatient rehabilitation services annually, with an aging population driving higher utilization of physiotherapy and post-acute care programs. The Centers for Medicare & Medicaid Services (CMS) reports sustained growth in Medicare beneficiaries accessing rehabilitation for stroke, orthopedic surgery, and neurological conditions. Repetitive, guided movement support from robotic devices can improve outcomes. Robots equipped with adaptive control, gait assistance, and activity feedback help therapists deliver consistent therapy sessions, track progress, and scale care across larger patient volumes. Integrating these systems into rehab centers supports standardized therapy regimens and helps address workforce shortages by extending clinician capacity without compromising quality of care.

Federal workforce and aging statistics also highlight the expanding role of rehabilitation in long-term care planning. The U.S. Bureau of Labor Statistics (BLS) projects that employment for physical and occupational therapy assistants will grow faster than average through the decade, reflective of increased service demand as populations age and survive complex illnesses at higher rates. Robots designed for rehabilitation, such as gait trainers, upper-limb support systems, and balance aids, enhance therapy intensity and consistency, offering measurable activity data that supports clinical decision-making and insurance documentation.

Product Type Insights

Fixed-base robots are expected to lead, with over 55% share in 2026, owing to widespread adoption in clinical and therapeutic environments where stable platforms provide consistent support for users. These systems are commonly used in rehabilitation centers, physical therapy labs, and long-term care facilities for tasks such as gait training, balance assistance, and upper-limb therapy. The structured nature of these settings suits non-mobile platforms, which can be integrated with existing treatment protocols and safety infrastructure more easily than mobile alternatives. The Lokomat system developed by Hocoma AG is a fixed, treadmill-mounted gait rehabilitation exoskeleton cleared for clinical use and widely deployed in rehabilitation centers to help patients with neurological injuries retrain walking patterns.

Mobile robots represent the fastest-growing product type, due to their flexibility and autonomous navigation capabilities that support diverse settings such as hospitals, homecare, and long-term care facilities. While mobile platforms are growing faster, fixed-base systems continue to lead overall market share owing to their longer presence, established clinical use, and integration into existing therapy and care workflows. An example is the autonomous hospital robot developed by Aethon. Aethon’s mobile robots are widely deployed in hospitals and long-term care facilities to autonomously navigate corridors and elevators while transporting medicines, linens, and medical supplies. This flexibility allows use across dynamic environments such as inpatient wards, outpatient units, and care homes, reducing staff workload and improving response time.

Application Analysis

Elderly or disability assistance is projected to dominate the market, accounting for 42% market share in 2026, fueled by rising demand for daily living support, mobility aid, and continuous monitoring in care settings. Government demographic data show a rapid increase in aging populations that require long-term assistance. Public health agencies also report high prevalence of mobility limitations among older adults, driving adoption of robotic mobility aids, patient transfer robots, and smart assistance platforms that improve independence, safety, and care efficiency in both institutional and home environments. An example of elderly assistance is Robear, developed by RIKEN and SUMITOMO RIKO Company Limited. Robear is a healthcare support robot designed to safely lift and transfer patients from beds or wheelchairs while protecting caregivers from injury.

Surgery assistance is likely to be the fastest-growing application, driven by increasing surgical volumes, workforce shortages, and demand for higher precision in operating rooms. Government health statistics show sustained growth in surgical procedures across public hospitals, increasing pressure on surgical teams to improve efficiency and consistency of care. Public healthcare systems have also prioritized technology adoption to improve patient safety, reduce surgeon fatigue, and support minimally invasive procedures. The Da Vinci Surgical System from Intuitive Surgical, Inc., is widely adopted in hospitals for minimally invasive procedures. In India’s public healthcare system, All India Institute of Medical Sciences (AIIMS) in New Delhi performed robot-assisted kidney transplants using the da Vinci Xi system, demonstrating how robotic platforms support complex surgeries with enhanced precision, smaller incisions, and better outcomes for patients.

North America Assistive Robots Market Trends

North America is projected to dominate, capturing 38% of revenue in 2026, supported by strong clinical adoption, reimbursement pathways, and a mature innovation ecosystem. The region benefits from early integration of assistive technologies across hospitals, rehabilitation centers, and homecare programs. Regulatory clarity from bodies such as the U.S. Food and Drug Administration helps accelerate clinical deployment of medical and assistive robotics through defined pathways for safety and efficacy review. Public research funding and translational programs from the National Institutes of Health and the National Science Foundation continue to expand robotics applications in mobility support, neurorehabilitation, and elder care, improving readiness for real-world use.

Demographic pressure adds momentum. Government statistics show a rising older-adult population in the U.S. and Canada, increasing demand for mobility assistance, fall prevention, and post-acute rehabilitation support delivered in clinical and home settings. Health systems in North America also lead in piloting robotics within value-based care models, where assistive devices improve therapy adherence and clinician productivity. Strong hospital purchasing power, established reimbursement pilots for rehabilitation technologies, and partnerships between academic medical centers and robotics manufacturers sustain commercialization at scale.

Europe Assistive Robots Market Trends

Europe is advancing on the back of strong healthcare infrastructure, demographic shifts, and coordinated regulatory frameworks that support innovation and safe deployment of robotic technologies. Member states within the European Union continue to harmonize medical device regulation under the EU Medical Device Regulation (MDR), which strengthens clinical evaluation, safety monitoring, and conformity assessment for robots used in clinical and care settings. This regulatory transparency encourages manufacturers to bring assistive solutions for rehabilitation, elderly support, and surgical assistance to market with clear compliance pathways. Public research partnerships funded through programs like Horizon Europe invest in collaborative robotics innovation, driving early demonstration projects in rehabilitation clinics, long-term care facilities, and community health environments.

Europe’s aging population is a central driver of assistive robot adoption, with government statistics showing that countries such as Italy, Germany, and Spain are among the fastest-aging societies globally, increasing demand for mobility support, fall detection, and daily assistance technologies. National health systems are testing robotics within homecare and outpatient therapy programs, aiming to improve quality of life while managing workforce shortages in elder care. Cross-border initiatives on data interoperability and safety standards also reduce barriers for robots that integrate with digital health records and care planning tools.

Asia Pacific Assistive Robots Market Trends

Asia Pacific is likely to be the fastest-growing market, powered by manufacturing scale, policy support, and rapid clinical adoption. Cyberdyne Inc. continues to deploy wearable exoskeletons in hospitals and rehabilitation centers across Japan, accelerating clinical acceptance of robotic mobility aids. China’s large-scale electronics and robotics manufacturing base shortens production cycles and reduces unit costs, enabling faster diffusion of mobile care robots in hospitals and community care facilities. India’s demographic transition toward an older population is increasing demand for mobility assistance and home-based rehabilitation, aligning with public health priorities to extend care beyond tertiary hospitals.

Government programs are catalyzing adoption at the system level. Singapore’s national digitalization agenda under Smart Nation Singapore supports pilots for homecare robotics, tele-rehabilitation, and sensor-enabled assisted living in public housing. Japan’s care sector reforms encourage technology-enabled eldercare to address workforce shortages, while China’s industrial policies prioritize domestic robotics capability for healthcare delivery. Across ASEAN, contract manufacturing and component ecosystems attract global OEMs to localize assembly and after-sales service, improving availability and uptime in clinical settings.

The global assistive robots market remains fragmented but is gradually consolidating, as both established players and emerging specialists compete to capture growing demand in healthcare, rehabilitation, and homecare applications. Leading companies such as Cyberdyne Inc. and Ekso Bionics Holdings, Inc. drive growth through proprietary exoskeleton designs and advanced wearable robotics, supported by strong intellectual property portfolios. Market strategies focus on research and development collaborations, AI-enabled performance enhancements, and integration of precise biofeedback systems to improve user outcomes.

Subscription-based service models are gaining traction in homecare, allowing patients and institutions to access robotics hardware bundled with tele-rehabilitation and remote monitoring, which reduces upfront costs and improves scalability. Rising startups contribute innovative solutions such as mobile assistance platforms and multi-sensor adaptive robots, increasing competition and accelerating adoption. The combination of strategic partnerships, technology differentiation, and flexible service offerings positions market players to meet expanding needs across hospitals, rehabilitation centers, and residential care environments, ultimately driving market consolidation while supporting rapid innovation.

Key Industry Developments:

• In November 2025, the wearable robot industry reached a new milestone as WIRobotics’ latest creation, WIM KIDS, won the CES 2026 Innovation Award in the Digital Health category. The award recognized the robot’s innovative design, which combines advanced technology with compassionate care to improve the quality of life for users. This achievement positioned WIRobotics at the forefront of the global robotics market, highlighting its role in transforming healthcare and mobility through wearable assistive technologies for people of all ages.
• In June 2025, Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leader in exoskeleton technology for medical and industrial applications, successfully demonstrated initial proof-of-concept for integrating artificial intelligence (AI) capabilities across its Enterprise Health and Personal Health exoskeleton devices. The company showcased how AI-enabled features could enhance device performance, user adaptability, and rehabilitation outcomes, marking a significant step in advancing intelligent wearable robotics for both clinical and industrial settings.